Prophylactic use of Lactobacillus reuteri DSM 17938 during the first 3 months of life significantly reduces colic, regurgitation, and constipation, according to a recent study.
Prophylactic use of Lactobacillus reuteri DSM 17938 during the first 3 months of life significantly reduces colic, regurgitation, and constipation, according to a recent study.
Researchers in Italy conducted a prospective, multicenter, double-masked, placebo-controlled, randomized trial involving 589 newborns from 9 different Italian neonatal units. The infants received either L reuteri DSM 17938 drops (essentially the type of probiotic found in yogurt) or placebo every day for 90 days.
At the end of 3 months, the investigators found that the mean duration of crying time in the infants in the probiotic group was almost half that of the infants in the placebo group (38 minutes vs 71 minutes, respectively). Similarly, the mean number of times per day that the babies in the placebo group spit up was 4.6 versus 2.9 in the probiotic group, and the mean number of evacuations per day was 4.2 in the placebo group versus 3.6 in the probiotic group.
The researchers noted no adverse events and reported that the probiotic supplementation was well tolerated.
Not incidentally, the researchers calculated that the probiotic saved each family approximately $119 and saved the community approximately $140.
According to the American Academy of Pediatrics, about one-fifth of all babies develop colic, usually between the second and fourth weeks of life. Given that gastrointestinal disorders are one of the biggest problems of infancy, accounting for a significant number of physician visits and a significant amount of parental anxiety, exhaustion, and stress, the investigators conclude that additional research should focus on validating probiotics as a cost-effective approach to colic.
To get weekly clinical advice for today's pediatrician, subscribe to the Contemporary Pediatrics eConsult.
Stress ulcer prophylaxis does not provide prevention of gastrointestinal bleeding in neonates
December 4th 2023In a poster abstract presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting & Exhibition held in Anaheim, California, stress ulcer prophylaxis (SUP) did not appear to provide benefit for prevention of gastrointestinal bleeding and did not increase SUP-associated adverse effects.
Hematocrit levels in newborns: EPP vs DCC study reveals surprising findings
November 15th 2023A recent study in JAMA Network Open investigates the impact of extrauterine placental perfusion versus delayed cord clamping on hematocrit levels in newborns, shedding light on potential alternatives for optimizing infant outcomes during birth.
Preterm infant HRQOL: Long-term impacts and determinants
October 21st 2023A recent study was highlighted at the 2023 American Academy of Pediatrics National Conference & Exhibition that shed light on the long-term impact of very preterm birth on the health-related quality of life (HRQOL) of infants and identified key determinants.